| Name | Title | Contact Details |
|---|
National Clinical Research is a Richmond, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Welcome to LunchboxWax, a place that proves that chic and cheeky do, in fact, co-exist. Our refined, unique speed-waxing technique means smooth skin is just minutes away. You won`t be at LunchboxWax long, but while you`re here, you`ll feel like you`re the only one who matters. Because to us, you are. Great things happen when you choose to do one thing and do it well. That`s why we believe our Lunchbox waxologists are the best. They`re committed to their craft and your happiness. It`s all they do. Just like we handpick our waxologists, we assemble other experts to make our business run as smooth as your skin after a LunchboxWax Brazilian. Yep, we just said that. Our business formula works, and we`re excited to share it through the LunchboxWax Franchise System.
Since 1976, Salter Labs has positioned itself to approach both the hospital and home care markets with products reflecting both innovation and exceptional quality.
HealthStream (NASDAQ: HSTM) is dedicated to improving patient outcomes through the development of healthcare organizations` greatest asset: their people. Our solutions are used by healthcare organizations to meet their regulatory training requirements, increase patient resuscitation rates, improved their patients’ experiences of care, train their employees on the new ICD-10 coding system, manage the credentialing process of their workforce, expedite employees’ onboarding processes, streamline competency & performance management, and to meet many other requirements, goals, and objectives. With our corporate office based in Nashville, TN, HealthStream has additional offices in Laurel, MD, Brentwood, TN, Pensacola, FL, Jericho, NY, San Diego, CA, and Nashville, TN (Highland Ridge Office).)
MRI Interventions, Inc. is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Since our inception in 1998, we have focused on research and product development in the field of interventional MRI. From 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. We have two product platforms. Our ClearPoint® system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. Our ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital’s existing MRI suite. Our products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Our ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases. Our ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. We believe that our two product platforms, subject to appropriate regulatory clearance and approval, will provide better patient outcomes, enable physicians and hospitals to treat more patients, and reduce costs to the healthcare system.